The high prevalence and increasing incidence of obesity and associated cardiovascular risk emphasises the need to focus on obesity reduction in this high-risk population.

Metabolic syndrome (MetS) is the coexistence of obesity-related cardiovascular risk factors including hypertension, diabetes and dyslipidaemia. MetS is a precursor for atherosclerosis, including premature coronary artery disease, and cardiovascular mortality.
 

This educational hub has been supported by Boehringer Ingelheim. Boehringer Ingelheim has had no influence over the content. This educational hub is not intended for UK or IRELAND based physicians.